NCT00186368

Brief Summary

The purpose of this study is to investigate gene expression profiles and biologic features of prostate tissue and how they relate to prostate cancer development and growth.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
867

participants targeted

Target at P75+ for all trials

Timeline
Completed

Started Apr 1999

Longer than P75 for all trials

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

April 6, 1999

Completed
6.4 years until next milestone

First Submitted

Initial submission to the registry

September 13, 2005

Completed
3 days until next milestone

First Posted

Study publicly available on registry

September 16, 2005

Completed
3.6 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

April 21, 2009

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

April 21, 2009

Completed
Last Updated

January 12, 2026

Status Verified

January 1, 2026

Enrollment Period

10 years

First QC Date

September 13, 2005

Last Update Submit

January 8, 2026

Conditions

Prostate Cancer

Keywords

Prostate cancerGene expressiontumor markersmicroarray analysis

Outcome Measures

Primary Outcomes (1)

  • Correlate genotype with pathologic phenotype and clinical outcome.

    The Tissue Bank will store all "Tissue Bank" consents. The patients will be given a unique identifier by the tissue bank. However, patients will need to be identified to link to clinical data and possible followup (if they have consented) via chart or tumor registries.

    one time

Eligibility Criteria

Age18 Years+
Sexmale
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

Per the original application in 1999: After obtaining informed consent (via the Tissue Bank consent), Protocol # 13873 (Continuing Review) PROTOCOL Print Date: September 22, 2010 PD: James Duane Brooks APPLICATION FORM Page 11 of 22 Review Type: Expedited Human Subjects Research Medical Stanford University Title: Microarray Analysis of Gene Expression in Prostatic Tissues (SQL 76528) Approval Period: 07/31/2010 - 06/30/2011 specimens will be collected from the Stanford University Department of Pathology (Tissue Bank) for patients treated at Stanford. Patients will be followed up via chart or tumor registries. Data will be used strictly for research purposes. Gene expression arrays are done in Dr. Brook's laboratory.

You may qualify if:

  • \- Patient scheduled to undergo either a biopsy or surgery for a prostate condition.

You may not qualify if:

  • \- Patients without a prostate condition

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Stanford University Cancer Center

Stanford, California, 94305, United States

Location

MeSH Terms

Conditions

Prostatic Neoplasms

Condition Hierarchy (Ancestors)

Genital Neoplasms, MaleUrogenital NeoplasmsNeoplasms by SiteNeoplasmsGenital Diseases, MaleGenital DiseasesUrogenital DiseasesProstatic DiseasesMale Urogenital Diseases

Study Officials

  • James Brooks, MD

    Stanford University

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
observational
Observational Model
OTHER
Time Perspective
PROSPECTIVE
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Professor Clinical (Primary) Uro-Oncology

Study Record Dates

First Submitted

September 13, 2005

First Posted

September 16, 2005

Study Start

April 6, 1999

Primary Completion

April 21, 2009

Study Completion

April 21, 2009

Last Updated

January 12, 2026

Record last verified: 2026-01

Data Sharing

IPD Sharing
Will not share

Locations

US(1)